Amitriptyline has been a generic for decades, and its API price is still tied to the petrochemical market. ChemAnalyst's amitriptyline hydrochloride price index rose quarter-over-quarter in the US, China and Germany in Q1 2026, the first quarter in a year when all three moved up together. The cause was feedstock: benzene and phthalic anhydride both rose sharply in Q1. For generic formulators, that shows how far back in the chemical chain an API's cost can start.
Key numbers
- United States, Q1 2026: up, on surging feedstock costs (producer prices up 4.0% in March)
- China, Q1 2026: up, on rising factory-gate prices
- Germany, Q1 2026: up, on a jump in energy costs
- Bangladesh, March 2026: BP-grade amitriptyline at USD 31/kg CFR
- The shift: China fell in Q3 and Q4 2025, and Germany was flat and then fell
From benzene to the API
Amitriptyline is a tricyclic compound, and its three-ring core is built from basic aromatic chemicals. Benzene and o-xylene lead to phthalic anhydride, and phthalic anhydride is a starting material for the ring intermediate amitriptyline is made from. A move in benzene or xylene therefore reaches the API after a delay of several steps.
In Q1 2026, those inputs moved together.
- United States: benzene costs surged in March on geopolitical tensions and regional maintenance shutdowns, and phthalic anhydride supply became severely constrained. Disruption to Middle East shipping routes also cut chemical feedstock imports through the quarter.
- China: phthalic anhydride costs rose gradually through Q1, and Brent crude surged in March, raising costs across the petrochemical chain.
- Germany: mixed xylene costs rose in February, and European natural gas spot prices surged in March on the same Middle East shipping disruptions.
Why the regions had been moving apart
Through late 2025, the US kept rising while Asia and Europe softened. China's index fell in Q4 2025 as producer prices dropped 1.9% and chemical overcapacity pushed prices down. Germany also declined as producer prices fell 2.5%. In Q1, one feedstock shock reached every producing region, and the gap closed.
Demand is steady, so costs set the price
Amitriptyline is prescribed for depression, nerve pain and migraine prevention, so demand changes little with prices or the economy. ChemAnalyst describes US drug production as stable and Germany's demand as supported by an aging population. When demand barely moves, the API price follows production costs. That makes feedstocks the most useful thing for buyers to watch.
What buyers should do before the next contract
- Track benzene, xylene and phthalic anhydride. These move before the API does. A sustained rise in benzene is an early warning for this molecule.
- Check the grade. USP, BP and EP grades are priced differently. ChemAnalyst's Bangladesh figure is BP grade on CFR terms, so convert any quote to the same basis before comparing.
- Avoid fixing at a peak. With feedstocks swinging on Middle East shipping news, contracts with a feedstock-linked review clause protect both sides.
Outlook
The key question is whether Q1's feedstock spike carried into Q2. ChemAnalyst's next quarterly update will show it. Until then, buyers should treat the Q1 increase as a cost pass-through that may partly reverse if benzene and shipping costs ease.
Track regional amitriptyline hydrochloride prices and forecasts on the ChemAnalyst amitriptyline hydrochloride price page.
Comments